The Department of Pharmaceuticals has invited applications from eligible applicants under two sub-schemes of the Scheme for Strengthening of Medical Device Industry (SMDI). The notice covers the Marginal Investment Scheme for Reducing Import Dependence and the Medical Device Clinical Studies Support Scheme. Applications must be submitted through the designated online portal by 23 July 2026, 6:00 PM, in accordance with the prescribed eligibility requirements.
The Department of Pharmaceuticals has issued a notice inviting applications under the Scheme for Strengthening of Medical Device Industry (SMDI). The notice provides an opportunity for eligible applicants to seek support under two sub-schemes aimed at strengthening the medical device sector. Interested applicants are required to follow the prescribed application procedure and satisfy the eligibility conditions specified by the Department. Detailed scheme guidelines are available on the Department of Pharmaceuticals website.
Key highlights include:
- Applications are invited under the Marginal Investment Scheme for Reducing Import Dependence.
- Applications are also invited under the Medical Device Clinical Studies Support Scheme.
- Proposals must be submitted through the designated online portal.
- The Department has published eligibility criteria and application guidelines on its official website.
- The last date for submitting applications is 23 July 2026 by 6:00 PM.
The notice invites eligible organisations to apply under the notified SMDI sub-schemes.